How Much Does Actos (Pioglitazone) Cost in Mississippi in 2026?

Generic Pioglitazone Prices Across Mississippi Pharmacies

The single biggest factor in what you pay for pioglitazone in Mississippi is whether you fill the generic or brand-name version. Generic pioglitazone tablets are widely stocked at chain and independent pharmacies throughout the state, and the average 2026 cash price sits near $15 for a 30-day supply.

Brand-name Actos, manufactured by Takeda, carries a list price of roughly $60 per month. That figure reflects the wholesale acquisition cost before any rebates or negotiated discounts. Since pioglitazone lost patent exclusivity years ago, generic competition has driven retail prices down sharply. Multiple generic manufacturers (Teva, Mylan, Zydus, and others) supply the Mississippi market, which keeps pricing competitive even at pharmacies without formal discount agreements.

Prices can still vary by $5 to $12 between pharmacies in the same city. A 2024 analysis by the National Academy for State Health Policy found that pharmacy-level pricing variation for generic diabetes medications was most pronounced in rural areas with fewer competing pharmacies, a pattern that applies directly to Mississippi's Delta and Pine Belt regions. Checking prices at two or three pharmacies before filling, or using a free GoodRx or RxSaver coupon, can shave a few dollars off even an already low generic cost.

At $15 per month, pioglitazone ranks among the cheapest oral antidiabetic agents in Mississippi. For comparison, brand-name SGLT2 inhibitors such as empagliflozin (Jardiance) run $550 or more monthly without insurance, and even generic metformin typically costs $4 to $10 at discount retailers.

Mississippi Medicaid and Pioglitazone Coverage

Pioglitazone is not listed on the Mississippi Division of Medicaid's preferred drug list as of 2026. That means Medicaid beneficiaries cannot fill it as a first-line covered medication without a prior authorization request from their prescriber.

Mississippi Medicaid operates a fee-for-service model alongside its managed care organizations (Magnolia Health, UnitedHealthcare Community Plan, and Molina Healthcare). Each MCO maintains its own formulary, but all three currently follow the state's exclusion of pioglitazone from preferred status. A prescriber can submit a prior authorization if the patient has documented intolerance or inadequate response to preferred agents (typically metformin and a sulfonylurea). Approval is not guaranteed, and the turnaround time averages 48 to 72 hours according to CMS state Medicaid reporting data.

For Medicaid beneficiaries who cannot obtain prior authorization, the generic cash price of $15 per month may be feasible as an out-of-pocket option. Mississippi ranks among the highest states for type 2 diabetes prevalence, with the CDC reporting a diagnosed rate of 14.2% among adults in its most recent state-level surveillance data. That prevalence makes formulary gaps especially consequential.

Insurance Coverage for Pioglitazone in Mississippi

Most commercial insurance plans and Medicare Part D plans in Mississippi do cover generic pioglitazone, typically on Tier 1 or Tier 2 of their formularies. Brand-name Actos, when covered at all, usually falls on Tier 3 (preferred brand) with higher copays.

A Tier 1 generic copay in Mississippi commercial plans ranges from $0 to $15 per fill depending on the insurer and plan design. For a drug that already costs $15 at retail, this means insured patients often pay the same or less than the cash price. Some plans with $0 generic copays eliminate cost entirely for pioglitazone.

Medicare Part D plans vary more widely. The 2026 Inflation Reduction Act provisions cap total out-of-pocket Part D spending at $2,000 per year, a change that benefits Mississippi seniors on multiple medications even if pioglitazone itself is inexpensive. Within the major Part D plans serving Mississippi (Humana, SilverScript, Wellcare, AARP/UnitedHealthcare), generic pioglitazone appears on preferred generic tiers with copays between $0 and $10.

Employer-sponsored plans through Mississippi's larger employers, including Sanderson Farms, Ingalls Shipbuilding, and the state university system, generally include pioglitazone on their generic formulary without prior authorization.

The practical advice: if you have any form of prescription coverage, check whether your plan's copay for pioglitazone is actually lower than the $15 cash price. Sometimes paying cash with a discount coupon beats running it through insurance, especially for patients in a high-deductible plan who haven't yet met their deductible.

The Takeda Savings Card and Other Discount Programs

Takeda, the manufacturer of brand-name Actos, offers a savings card program that reduces copays for commercially insured patients. The card is not valid for patients covered by Medicare, Medicaid, TRICARE, or other government-funded programs. For eligible patients, the card can reduce a brand-name Actos copay to as low as $0 for a 30-day supply, depending on the plan's contracted price.

Because generic pioglitazone is already so inexpensive, the Takeda card is most useful for the small number of patients whose prescribers write for brand-name Actos specifically (some clinicians prefer brand in cases where patients report inconsistent responses across generic manufacturers).

Free discount coupons from platforms like GoodRx, RxSaver, and SingleCare can bring the generic price below $10 at participating Mississippi pharmacies. Walmart's $4 generic list previously included pioglitazone 15 mg tablets, though availability and pricing on that list can change quarterly. Costco pharmacies (the closest to most Mississippi residents is in neighboring states, but Costco pharmacy pricing is available to non-members) also offer competitive generic pricing.

For uninsured patients, several pharmaceutical assistance programs accept Mississippi residents. The Partnership for Prescription Assistance and state-level programs administered through Mississippi's federally qualified health centers can help connect patients to free or reduced-cost medications.

Compounded Pioglitazone in Mississippi

Compounded pioglitazone is legal in Mississippi when prepared by a licensed 503A compounding pharmacy operating under a valid prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits patient-specific compounding by state-licensed pharmacies when a prescriber determines that a commercially available form does not meet the patient's needs.

Legitimate reasons for compounding pioglitazone include allergy to an inactive ingredient in the commercial tablet, need for a non-standard dose not available as a manufactured tablet, or difficulty swallowing tablets (a compounding pharmacy can prepare a liquid suspension). The cost for compounded pioglitazone varies widely but can range from $20 to $50 per month depending on the pharmacy and formulation.

One important distinction: 503A compounding is patient-specific and requires a prescription. 503B outsourcing facilities can compound without individual prescriptions for office use, but pioglitazone is not commonly produced through 503B channels because the commercial generic is already inexpensive and widely available.

Mississippi's Board of Pharmacy oversees compounding pharmacies within the state. Patients should verify that any compounding pharmacy they use holds a current Mississippi state license and complies with USP 795 standards for non-sterile compounding. The FDA maintains a list of drugs that may not be compounded under federal law, and pioglitazone does not appear on that restricted list.

Telehealth Access to Pioglitazone in Mississippi

Mississippi permits telehealth prescribing of pioglitazone. A licensed prescriber can evaluate a patient via audio-video telehealth, diagnose or confirm type 2 diabetes (or an off-label indication), and transmit a prescription to any Mississippi pharmacy electronically.

Mississippi passed its Telehealth Act in 2017 and has since expanded prescribing authority to cover most non-controlled substances. Pioglitazone is not a controlled substance, so it faces no additional telehealth prescribing restrictions. The prescriber must hold a valid Mississippi medical license or be authorized through an interstate compact.

Telehealth platforms that serve Mississippi residents (HealthRX, Sesame, PlushCare, and others) can prescribe pioglitazone after a virtual consultation. This is especially relevant for patients in the Mississippi Delta and other rural areas where endocrinologists are scarce. Mississippi has approximately 3.8 endocrinologists per 100,000 residents according to Endocrine Society workforce data, well below the national average.

A telehealth visit for diabetes management typically costs $50 to $150 without insurance. Combined with the $15 monthly generic cost, total first-month spending for a new pioglitazone prescription obtained via telehealth runs roughly $65 to $165 out of pocket.

Clinical Value: Why Pioglitazone Remains Relevant

Pioglitazone belongs to the thiazolidinedione (TZD) class. It works by activating PPAR-gamma receptors, which increases insulin sensitivity in muscle, fat, and liver tissue. The FDA approved pioglitazone in 1999 for type 2 diabetes as an adjunct to diet and exercise.

Beyond glucose control, pioglitazone has accumulated evidence for cardiovascular benefit and liver fat reduction. The PROactive trial (N=5,238) demonstrated a 16% reduction in the composite secondary endpoint of all-cause mortality, non-fatal myocardial infarction, and stroke in patients with type 2 diabetes and macrovascular disease [1]. The PIVENS trial (N=247) showed that pioglitazone 30 mg daily produced significant improvement in hepatic steatosis and lobular inflammation compared to placebo in patients with non-alcoholic steatohepatitis (NASH) without diabetes [2].

"Pioglitazone is one of the few diabetes drugs with randomized trial evidence supporting a benefit in both cardiovascular risk and liver histology," noted the American Association of Clinical Endocrinology (AACE) 2023 Consensus Statement on Type 2 Diabetes Management.

The drug does carry known risks. Fluid retention and weight gain (typically 2 to 4 kg over 12 months) are common. The FDA issued a safety communication regarding a possible increased risk of bladder cancer with prolonged use exceeding 12 months, though subsequent meta-analyses have produced conflicting results. A 2021 systematic review published in The Lancet Diabetes & Endocrinology found no statistically significant bladder cancer signal at standard doses and durations.

Pioglitazone is contraindicated in patients with NYHA Class III or IV heart failure. Prescribers in Mississippi should obtain baseline and periodic BNP or NT-proBNP levels in patients with any history of cardiac dysfunction.

For Mississippi patients with type 2 diabetes and concomitant MASH (metabolic dysfunction-associated steatohepatitis), pioglitazone at 30 to 45 mg daily remains a guideline-supported option at a fraction of the cost of newer agents like resmetirom (Rezdiffra), which carries a list price exceeding $2,000 per month.

How to Get the Lowest Price in Mississippi

The most cost-effective path for most Mississippi residents: ask your prescriber to write for generic pioglitazone (not brand Actos), fill at a high-volume chain pharmacy (Walmart, Kroger, CVS), and present a free GoodRx or RxSaver coupon at the counter. Expected cost: $8 to $15 per month.

If you have commercial insurance with a $0 generic tier, use your insurance card instead. If you carry Medicare Part D, your plan's negotiated price for pioglitazone will almost certainly fall below $10 after the 2026 out-of-pocket cap provisions take effect.

For Medicaid beneficiaries, pursue prior authorization through your prescriber's office. Document previous trials of metformin and a sulfonylurea, and note any clinical rationale for pioglitazone specifically (MASH, insulin resistance with contraindications to other agents). If PA is denied, the $15 cash price is within reach for most patients, though financial hardship programs through FQHCs can further reduce or eliminate cost.

Pioglitazone 30 mg once daily with or without food. No titration period is required, though some prescribers start at 15 mg and increase after 4 to 8 weeks based on A1c response and tolerability [3].